Remark(s)
|
relatively reduced telomere length in patients fibroblasts and stricking nuclear abnormalities , which may also play a key role in short replicative life span and /or an independent role in the pathogenesis
alterations in mitosis and cell cycle progression caused by the mutant Delta50 lamin A known to accelerate human aging
NEMO (IKBKG) shuttle may link genotoxic stress to the activation of innate immunity system and cause premature aging via inflamm-aging process
expression of progerin leads to alterations in nuclear morphology in keratinocyte that are reversed by inhibition of farnesyltransferasae, but epidermal expression does not lead to alopecia or other skin abnormalities
defects in the DNA repair machinery in patients suffering from progeroid syndromes due to expression of LAÄ50/progerin or abnormal levels of farnesylated pre-lamin A. (PMID: 17360326))
somatic cells from patients, despite their significant premature senescence phenotypes and nuclear defects, have been properly reprogrammed and can be effectively maintained in a pluripotent state (PMID: 21346760))
mutant acts as a dominant negative protein that changes the structure of the nuclear lamina, disrupts the nucleocytoplasmic RAN gradient and inhibits nuclear localization of UBE2I (PMID: 2167015)
mutation changes the accessibility of the 5 prime SS of LMNA exon 11 which is sequestered in a conserved RNA structure (PMID: 21875900))
cellular senescence of HGPS fibroblasts is corrected by depletion of SUN1 (PMID: 22541428))
mutation during osteoblast development results in loss of osteocytes, irregular mineralization, and poor biomechanical properties (PMID: 22893709))
lonafarnib therapy increased the rate of weight gain and improved measures of cardiovascular stiffness, bone structure, or audiological status (PMID: 23012407))
association with telomeres is impaired in PRO1, and this impaired interaction is central to disease since increasing TMPO levels rescues progerin-induced proliferation defects and loss of H3K27me3, whereas loweringTMPO levels exacerbates progerin-induced defects (PMID: 26312502)) |